Maintaining adequate blood supply to support patient needs is a critical responsibility of hospital Transfusion Services. Inventory management is a challenge because supply and demand are unpredictable, made worse recently by a pandemic, wildfires, and social unrest. In addition to threats to the inventory, another challenge is the increasing variety of products such as the 9 platelet options provided by the Food and Drug Administration Guidance, “Bacterial Risk Control Strategies for Blood Collection Establishments and Transfusion Services to Enhance the Safety and Availability of Platelets for Transfusion.” This session will provide strategies for inventory management of red blood cells, platelets, plasma and cryoprecipitate and compare approaches suitable for Transfusion Services 1) during different levels of shortage 2) in rural versus urban settings 3) that serve different patient populations and clinical services 4) with and without a donor center.
To view Spanish or English subtitles, click the "CC" box in the video player. Para ver subtítulos en español o inglés, haga clic en el cuadro "CC" en el reproductor de video.
Compare approaches for routine inventory management of red blood cells, platelets, plasma and cryoprecipitate for transfusion services in different practice settings
Discuss general strategies for inventory management of red blood cells, platelets, plasma and cryoprecipitate during supply challenges
Recognize the risks and describe plans at different centers for managing multiple types of platelet products (e.g., large volume delayed sampling, pathogen reduced, platelet additive solution) with different allowable product shelf-lives.
Associate Professor for the Dept. of Pathology and Lab Medicine; Associate Medical Director of Transfusion Service and Medical Director of Blood Bank,
Dartmouth-Hitchcock Medical Center
Medical Director of Blood Bank and Transfusion Medicine, Assistant Professor of Pathology and Laboratory Medicine,
Boston Medical Center